The global law firm Freshfields has advised Ottobock SE & Co. KGaA in its investment in the Dutch listed NeuroTech company ONWARD Medical N.V.. The investment is being done in the context of a Cornerstone Investment Agreement with Ottobock in connection with a capital increase announced by Onward. The international Freshfields team advised on capital market and corporate law issues relating to the investment.

Partner Christoph H. Seibt and Associate Jean Mohamed (both Corporate/M&A, Hamburg); Partner Dirk-Jan Smit, Counsel Zach Truscott, Associate Lasse de Vooght (all Corporate/M&A, Amsterdam); Senior Associate Katie Bentel (Corporate/M&A, London); Senior Associate Max Immerzeel (Antitrust, Amsterdam); Special Counsel Christine Laciak (Antitrust, Washington).